Wealth Enhancement Advisory Services’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Buy
+31,387
New +$281K ﹤0.01% 3230
2025
Q3
Sell
-10,695
Closed -$72.7K 3667
2025
Q2
$72.7K Buy
+10,695
New +$70.8K ﹤0.01% 3184
2025
Q1
Sell
-11,688
Closed -$94K 3101
2024
Q4
$94K Sell
11,688
-5,238
-31% -$50.5K ﹤0.01% 2812
2024
Q3
$214K Buy
+16,926
New +$219K ﹤0.01% 2407

Other funds holding NVAX

Wealth Enhancement Advisory Services's NVAX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Novavax (NVAX) in Q2 2026: 31,387 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #3230 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in NVAX as recently as Q2 2025.

Wealth Enhancement Advisory Services first reported a position in NVAX in Q3 2024 and has held it in 4 quarters since. 26 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 31,387 shares of Novavax worth $293K as of Q2 2026.
  • Novavax was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Novavax made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3230 holding.
  • Wealth Enhancement Advisory Services first reported a position in Novavax in Q3 2024 and has held it in 4 quarters since.
  • 26 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.